These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 29510896

  • 41. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM, Mikkola JA, Laine K, Airaksinen M.
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [Abstract] [Full Text] [Related]

  • 42. Incidence of potential drug-drug interactions with antidiabetic drugs.
    Samardzic I, Bacic-Vrca V.
    Pharmazie; 2015 Jun; 70(6):410-5. PubMed ID: 26189304
    [Abstract] [Full Text] [Related]

  • 43. Clinical decision support systems differ in their ability to identify clinically relevant drug interactions of immunosuppressants in kidney transplant patients.
    Amkreutz J, Koch A, Buendgens L, Trautwein C, Eisert A.
    J Clin Pharm Ther; 2017 Jun; 42(3):276-285. PubMed ID: 28224645
    [Abstract] [Full Text] [Related]

  • 44. Evaluation of drug-drug interactions in cancer patients treated at a university hospital in North Cyprus using two interaction databases.
    Laban AA, Birand N, Chukwunyere U, Abdi A, Basgut B.
    Niger J Clin Pract; 2021 Jul; 24(7):1067-1071. PubMed ID: 34290184
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Assessment tool for pharmacy drug-drug interaction software.
    Warholak TL, Hines LE, Saverno KR, Grizzle AJ, Malone DC.
    J Am Pharm Assoc (2003); 2011 Jul; 51(3):418-24. PubMed ID: 21555296
    [Abstract] [Full Text] [Related]

  • 48. Incidence of Drug Interactions Identified by Clinical Pharmacists in Veterans Initiating Treatment for Chronic Hepatitis C Infection.
    Ottman AA, Townsend ML, Hashem MG, DiMondi VP, Britt RB.
    Ann Pharmacother; 2018 Aug; 52(8):763-768. PubMed ID: 29577765
    [Abstract] [Full Text] [Related]

  • 49. Potential drug-drug interactions in a medical intensive care unit of a university hospital.
    Gülçebi İdriz Oğlu M, Küçükibrahimoğlu E, Karaalp A, Sarikaya Ö, Demirkapu M, Onat F, Gören MZ.
    Turk J Med Sci; 2016 Apr 19; 46(3):812-9. PubMed ID: 27513261
    [Abstract] [Full Text] [Related]

  • 50. [Analysis of comorbidity and polypharmacy in middle-aged and elderly patients].
    Su BB, Ma JX, Song W, Yuan J, Dong XY, Wan J.
    Zhonghua Yi Xue Za Zhi; 2020 Jul 07; 100(25):1983-1987. PubMed ID: 32629601
    [Abstract] [Full Text] [Related]

  • 51. Consistency of psychotropic drug-drug interactions listed in drug monographs.
    Liu X, Hatton RC, Zhu Y, Hincapie-Castillo JM, Bussing R, Barnicoat M, Winterstein AG.
    J Am Pharm Assoc (2003); 2017 Jul 07; 57(6):698-703.e2. PubMed ID: 28844584
    [Abstract] [Full Text] [Related]

  • 52. Characterization of drug-drug interactions in patients whose substance intake was objectively identified by detection in urine.
    Schrecker J, Puet B, Hild C, Schwope DM.
    Expert Opin Drug Metab Toxicol; 2018 Sep 07; 14(9):973-978. PubMed ID: 30092669
    [Abstract] [Full Text] [Related]

  • 53. Frequency, severity, and factors associated with clinically significant drug-drug interactions among patients with cancer attending Mbarara Regional Referral Hospital Cancer Unit, Uganda.
    Luzze B, Atwiine B, Lugobe HM, Yadesa TM.
    BMC Cancer; 2022 Dec 05; 22(1):1266. PubMed ID: 36471270
    [Abstract] [Full Text] [Related]

  • 54. Drug-Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation.
    Li L, Baker J, Quirk R, Deidun D, Moran M, Salem AA, Aryal N, Van Dort BA, Zheng WY, Hargreaves A, Doherty P, Hilmer SN, Day RO, Westbrook JI, Baysari MT.
    Drug Saf; 2024 Jun 05; 47(6):557-569. PubMed ID: 38478349
    [Abstract] [Full Text] [Related]

  • 55. Drug Interactions in Space: a Cause for Concern?
    Berman E, Eyal S.
    Pharm Res; 2019 May 31; 36(8):114. PubMed ID: 31152244
    [Abstract] [Full Text] [Related]

  • 56. Sensitivity and specificity of drug interaction databases to detect interactions with recently approved oral antineoplastics.
    Bossaer JB, Eskens D, Gardner A.
    J Oncol Pharm Pract; 2022 Jan 31; 28(1):82-86. PubMed ID: 33435823
    [Abstract] [Full Text] [Related]

  • 57. Drug interactions in dying patients: a retrospective analysis of hospice inpatients in Germany.
    Frechen S, Zoeller A, Ruberg K, Voltz R, Gaertner J.
    Drug Saf; 2012 Sep 01; 35(9):745-58. PubMed ID: 22809376
    [Abstract] [Full Text] [Related]

  • 58. Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions.
    Langness JA, Nguyen M, Wieland A, Everson GT, Kiser JJ.
    World J Gastroenterol; 2017 Mar 07; 23(9):1618-1626. PubMed ID: 28321163
    [Abstract] [Full Text] [Related]

  • 59. Review of drug-drug interactions in patients with prostate cancer.
    Ruplin A, Segal E, McFarlane T.
    J Oncol Pharm Pract; 2024 Sep 07; 30(6):1057-1072. PubMed ID: 38720547
    [Abstract] [Full Text] [Related]

  • 60. A pilot study on the impact of known drug-drug interactions in cancer patients.
    Ussai S, Petelin R, Giordano A, Malinconico M, Cirillo D, Pentimalli F.
    J Exp Clin Cancer Res; 2015 Aug 25; 34(1):89. PubMed ID: 26303220
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.